ERβ expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis

References

• Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525–32.
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159–70.
   PubMed Web of Science ®Google Scholar
• Di Leo A, Messa C, Russo F, Misciagna G, Guerra V, Taveri R, Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig Dis Sci 1994;39:2038–42.
   PubMedGoogle Scholar
• Fernandez E, La Vecchia C, Braga C, Talamini R, Negri E, Parazzini F, Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 1998;7:329–33.
   PubMed Web of Science ®Google Scholar
• Notarnicola M, Gristina R, Messa C, Cariola F, Fiorente P, Caruso ML, Oestrogen receptors and microsatellite instability in colorectal cancer patients. Cancer Lett 2001;168:65–70.
   PubMedGoogle Scholar
• Tangrea JA, Albert PS, Lanza E, Woodson K, Corle D, Hasson M, Hormone replacement therapy and colorectal adenoma recurrence among women in the polyp prevention trial. Report J Natl Cancer Inst 2001;93:1799–805.
   PubMedGoogle Scholar
• Newcomb PA, Storer BE. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002;110:219–27.
   Google Scholar
• Weyant MJ, Carothers AM, Mahmoud NN, Bradlow HL, Remotti H, Bilinski RT, Reciprocal expression of ERα and ERβ is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res 2001;61:2547–51.
   PubMed Web of Science ®Google Scholar
• Javid SH, Moran AE, Carothers AM, Redston M, Bertagnolli MM. Modulation of tumor formation and intestinal cell migration by estrogens in the ApcMin/+ mouse model of colorectal cancer. Carcinogenesis 2005;26:587–95.
   PubMedGoogle Scholar
• Giroux V, Lemay F, Bernatchez G, Robitaille Y, Carrier JC. Estrogen receptor beta deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice. Int J Cancer 2008;123:303–11.
   PubMed Web of Science ®Google Scholar
• Barone M, Tanzi S, Lofano K, Scavo MP, Pricci M, Demarinis L, Dietary-induced ERβ upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Carcinogenesis 2010;31:269–74.
   PubMed Web of Science ®Google Scholar
• Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P, Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004;11:537–51.
   PubMed Web of Science ®Google Scholar
• Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 2005;14:17–21.
   PubMed Web of Science ®Google Scholar
• Kennelly R, Kavanagh DO, Hogan AM, Winter DC. Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 2008;9:385–91.
   PubMed Web of Science ®Google Scholar
• Talbot IC, Burt R, Jarvinen H, Thomas G. Familial Adenomatous Polyposis (FAP), pathology and genetics of tumors of the digestive system. In: Stanley R, Hamilton Lauri A, editor. Aaltonen: IARC Press Lyon; 2000. pp 120–5.
   Google Scholar
• Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galtet J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 e MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin section. J Pathol 1992;168:357–63.
   PubMed Web of Science ®Google Scholar
• Parkin DM. International variation. Oncogene 2004;23:6329–40.
   PubMed Web of Science ®Google Scholar
• Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994;3:121–5.
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992;1:229–33.
   PubMedGoogle Scholar
• Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1:1–24.
   Google Scholar
• Fearnhead NS. The ABC of the APC. Hum Mol Genet 2001;7:721–733.
   Google Scholar
• Cho NL, Javid SH, Carothers AM, Redston M, Bertagnolli MM. Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 2007;67:2366–72.
   PubMedGoogle Scholar
• Cleveland AG, Oikarinen SI, Bynoté KK, Marttinen M, Rafter JJ, Gustafsson JA, Disruption of estrogen receptor signaling enhances intestinal neoplasia in APCMin/+ Mice. Carcinogenesis 2009;30:1581–90.
   PubMedGoogle Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Risk and benefit of estrogen plus progestin in health postmenopausal women: principals results from the Women's Health Initiative randomized controlled trial. JAMA 2002;3:321–33.
   Google Scholar
• Qiu Y, Waters CE, Lewis AE, Langman MJ, Eggo MC. Oestrogen induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 2002;174:369–77.
   PubMedGoogle Scholar
• Ierardi E, Di Leo A, Barone M, Marangi S, Burattini O, Panarese A, Tumor necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage a possible mechanism of immune system involvement in epithelial turnover regulation. Immunopharmacol Immunotoxicol 2003;25:203–11.
   PubMed Web of Science ®Google Scholar
• Gieseler F, Rudolph P, Kloeppel G, Foelsch UR. Resistance mechanism of gastrointestinal cancers: why does conventional chemotherapy fail? Int J Colorectal Dis 2003;18:470–480.
   PubMed Web of Science ®Google Scholar
• Pereira MA, Tao L, Wang W, Li Y, Umar A, Steele VE, Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-α gene in rat colon tumors. Carcinogenesis 2004;25:1917–23.
   PubMed Web of Science ®Google Scholar